Larimar Therapeutics (LRMR) PT Raised to $12 at Wedbush
Tweet Send to a Friend
Wedbush analyst Laura Chico raised the price target on Larimar Therapeutics (NASDAQ: LRMR) to $12.00 (from $11.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
